EUR 11.61
(-0.29%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 14.65 Million EUR | -3.36% |
2022 | 15.16 Million EUR | -0.82% |
2021 | 15.29 Million EUR | -8.15% |
2020 | 16.64 Million EUR | 545.96% |
2019 | 2.57 Million EUR | 0.0% |
2018 | - EUR | 0.0% |
2017 | - EUR | 0.0% |
2016 | - EUR | 0.0% |
2015 | - EUR | 0.0% |
2014 | - EUR | 0.0% |
2013 | - EUR | 0.0% |
2012 | - EUR | -100.0% |
2011 | 128.87 Thousand EUR | -49.15% |
2010 | 253.45 Thousand EUR | -0.99% |
2009 | 256 Thousand EUR | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 32.25 Million EUR | 0.0% |
2024 Q1 | 14.18 Million EUR | 0.0% |
2023 Q2 | 45 Million EUR | 13.75% |
2023 Q3 | 14.49 Million EUR | -67.78% |
2023 FY | 14.65 Million EUR | -3.36% |
2023 Q4 | 14.65 Million EUR | 1.08% |
2023 Q1 | 39.55 Million EUR | 160.87% |
2022 Q4 | 15.16 Million EUR | -3.11% |
2022 Q2 | 15.75 Million EUR | -14.13% |
2022 FY | 15.16 Million EUR | -0.82% |
2022 Q1 | 18.34 Million EUR | 20.0% |
2022 Q3 | 15.65 Million EUR | -0.67% |
2021 Q1 | 53.38 Million EUR | 220.71% |
2021 Q3 | 50.21 Million EUR | -0.66% |
2021 Q4 | 15.29 Million EUR | -69.55% |
2021 FY | 15.29 Million EUR | -8.15% |
2021 Q2 | 50.55 Million EUR | -5.31% |
2020 Q1 | - EUR | -100.0% |
2020 FY | 16.64 Million EUR | 545.96% |
2020 Q4 | 16.64 Million EUR | 153.07% |
2020 Q3 | 6.57 Million EUR | -5.13% |
2020 Q2 | 6.93 Million EUR | 0.0% |
2019 Q4 | 2.57 Million EUR | 0.0% |
2019 FY | 2.57 Million EUR | 0.0% |
2019 Q2 | - EUR | 0.0% |
2019 Q1 | - EUR | 0.0% |
2018 Q1 | - EUR | 0.0% |
2018 FY | - EUR | 0.0% |
2018 Q4 | - EUR | 0.0% |
2018 Q3 | - EUR | 0.0% |
2018 Q2 | - EUR | 0.0% |
2017 Q4 | - EUR | 0.0% |
2017 Q3 | - EUR | 0.0% |
2017 Q2 | - EUR | 0.0% |
2017 Q1 | - EUR | 0.0% |
2017 FY | - EUR | 0.0% |
2016 Q2 | - EUR | 0.0% |
2016 Q1 | - EUR | 0.0% |
2016 FY | - EUR | 0.0% |
2016 Q4 | - EUR | 0.0% |
2016 Q3 | - EUR | 0.0% |
2015 Q4 | - EUR | 0.0% |
2015 FY | - EUR | 0.0% |
2015 Q2 | - EUR | 0.0% |
2014 Q4 | - EUR | 0.0% |
2014 FY | - EUR | 0.0% |
2014 Q2 | - EUR | 0.0% |
2013 Q2 | - EUR | 0.0% |
2013 Q4 | - EUR | 0.0% |
2013 FY | - EUR | 0.0% |
2012 Q2 | 112 Thousand EUR | 0.0% |
2012 Q4 | - EUR | 0.0% |
2012 FY | - EUR | -100.0% |
2011 FY | 128.87 Thousand EUR | -49.15% |
2011 Q4 | 128.87 Thousand EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 Q4 | 253.45 Thousand EUR | 0.0% |
2010 FY | 253.45 Thousand EUR | -0.99% |
2010 Q2 | 253 Thousand EUR | 0.0% |
2009 Q4 | 256 Thousand EUR | 0.0% |
2009 FY | 256 Thousand EUR | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Cegedim SA | 188.54 Million EUR | 92.227% |
Guerbet SA | 360.51 Million EUR | 95.935% |
Nexus AG | 15.43 Million EUR | 5.072% |
Bastide Le Confort Médical SA | 291.04 Million EUR | 94.965% |
Revenio Group Oyj | 10.05 Million EUR | -45.821% |
Drägerwerk AG & Co. KGaA | 257.71 Million EUR | 94.313% |
Sartorius Aktiengesellschaft | 5.02 Billion EUR | 99.708% |
LNA Santé SA | 341.16 Million EUR | 95.704% |
Siemens Healthineers AG | 436 Million EUR | 96.639% |
Equasens Société anonyme | 39.51 Million EUR | 62.915% |
Stratec SE | 80.8 Million EUR | 81.863% |